These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16020915

  • 1. HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.
    Takahashi T, Ishii N, Itai K, Goto R, Higashi K, Kobori S.
    J Atheroscler Thromb; 2005; 12(3):149-53. PubMed ID: 16020915
    [Abstract] [Full Text] [Related]

  • 2. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y, Shouzu A, Nishikawa M, Yonemoto T, Shimizu H, Omoto S, Hayakawa T, Inada M.
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [Abstract] [Full Text] [Related]

  • 3. The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study.
    Duman D, Demirtunc R, Sahin S, Esertas K.
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1007-11. PubMed ID: 18163011
    [Abstract] [Full Text] [Related]

  • 4. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study.
    Mercuri M, Bond MG, Sirtori CR, Veglia F, Crepaldi G, Feruglio FS, Descovich G, Ricci G, Rubba P, Mancini M, Gallus G, Bianchi G, D'Alò G, Ventura A.
    Am J Med; 1996 Dec; 101(6):627-34. PubMed ID: 9003110
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M, Matsubara M, Arakawa E, Takada C, Ina Y, Hasegawa K, Yao K.
    Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
    [Abstract] [Full Text] [Related]

  • 6. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery.
    Kitahara M, Kanaki T, Toyoda K, Miyakoshi C, Tanaka S, Tamaki T, Saito Y.
    Jpn J Pharmacol; 1998 Jun; 77(2):117-28. PubMed ID: 9681568
    [Abstract] [Full Text] [Related]

  • 7. Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model.
    Bledsoe SL, Barr JC, Fitzgerald RT, Brown AT, Faas FH, Eidt JF, Moursi MM.
    Vasc Endovascular Surg; 2006 Jun; 40(1):49-57. PubMed ID: 16456606
    [Abstract] [Full Text] [Related]

  • 8. The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol.
    Reid JA, Wolsley C, Lau LL, Hannon RJ, Lee B, Young IS, Soong CV.
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):464-8. PubMed ID: 16099694
    [Abstract] [Full Text] [Related]

  • 9. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J, Willekes-Koolschijn N, Koomans H, Van Tol A, Geelhoed-Mieras T, Crommelin D, Van Bloois L, Krajnc-Franken M, Cohen L, Griffioen M.
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [Abstract] [Full Text] [Related]

  • 10. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
    de Sauvage Nolting PR, de Groot E, Zwinderman AH, Buirma RJ, Trip MD, Kastelein JJ.
    Arch Intern Med; 2001 Oct; 163(15):1837-41. PubMed ID: 12912721
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
    Alfon J, Guasch JF, Berrozpe M, Badimon L.
    Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration.
    Komukai M, Wajima YS, Tashiro J, Shinomiya M, Saito Y, Morisaki N.
    Scand J Clin Lab Invest; 1999 May; 59(3):159-66. PubMed ID: 10400160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.